Visit Certara at booth 112. We look forward to meeting you!
The drug discovery and development process is long and expensive with more failures than successes. At Certara, we anticipate and address your critical drug discovery and development risks and decisions using biosimulation, consulting services, and technology. Certara supports confident decision-making throughout the entire biopharma R&D process to reduce cycle times, lower costs and improve outcomes for patients.
Certara’s team of toxicology experts provide safety program design and management, due diligence activities, issue analysis and resolution, and regulatory submission preparation.
Certara is the developer of the SEND Explorer Product Family, a validated, web-based application that enables visualization of nonclinical study data, allowing teams to leverage their nonclinical research investment by using current and historical study data to support internal decision-making. Other Certara software products that facilitate streamlined drug development include Secondary Intelligence™ (which makes sense of your secondary pharmacology readouts), Phoenix™ PK/PD, Pinnacle 21 and Simcyp™ PBPK Simulator.
Brands: SEND Explorer Plus, SEND Explorer Warehouse, INDS